PMID: 6976063Aug 1, 1981Paper

Quantitation of complement C3b and C3d surface receptors on neoplastic IgM positive B lymphocytes

Acta Pathologica Et Microbiologica Scandinavica. Section C, Immunology
V JønssonA Videbaek

Abstract

C3b and C3d complement receptors on the surface of mononuclear cells from blood, lymph nodes, and spleens were investigated in twenty-nine CLL patients and in eight patients with non-Hodgkin malignant lymphoma. Compared with a normal material, especially the lymphoid tissues but also the blood of the patients contained a high number of C3d receptor positive lymphocytes with a strong expression of C3d receptors per cell. The majority of the cells with high C3d receptor expression also had SmIgM. The number of C3b receptor positive cells was decreased in the patients but the C3b receptor expression per cell was normal.

References

Mar 1, 1977·Scandinavian Journal of Haematology·V Jonsson, B E Christensen
Mar 1, 1978·Scandinavian Journal of Haematology·B E ChristensenO Tønder
Apr 1, 1978·British Journal of Cancer·H SteinK Lennert
May 1, 1975·The Journal of Experimental Medicine·G D Ross, M J Polley
Jan 1, 1976·Scandinavian Journal of Immunology·R Matre, O Tönder
May 1, 1976·Cellular Immunology·P Nieuwenhuis, W L Ford
Jan 1, 1976·Journal of Immunological Methods·A SaxonR A Robins
Apr 1, 1975·Journal of Immunological Methods·L Wong, J D Wilson
Jan 1, 1973·Scandinavian Journal of Immunology. Supplement·N Harboe, A Ingild
Dec 1, 1973·The Journal of Clinical Investigation·A EdenV Nussenzweig
Apr 11, 1974·The New England Journal of Medicine·E S JaffeI Green
Jan 1, 1974·Scandinavian Journal of Immunology·M Jondal
Sep 1, 1980·The Journal of Clinical Investigation·D P FineJ C Guckian
Apr 1, 1980·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·V U JønssonB E Christensen

❮ Previous
Next ❯

Related Concepts

Related Feeds

B-Cell Leukemia (Keystone)

B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.

Alternative Complement Pathway

The Alternative Complement Pathway is part of the innate immune system, and activation generates membrane attack complexes that kill pathogenic cells. Discover the latest research on the Alternative Complement Pathway.